December 2012 Editor's Picks: Products from Honeywell Process Solutions and Carl Zeiss Microscopy - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

December 2012 Editor's Picks: Products from Honeywell Process Solutions and Carl Zeiss Microscopy

Equipment and Processing Report

Featured products from Pharmaceutical Technology's monthly newsletter, Equipment & Processing Report

Honeywell Process Solutions
A smart pressure transmitter is redesigned for improved performance

The Smartline pressure transmitter from Honeywell Process Solutions enhances communication abilities, improves operational efficiency, and reduces lifecycle costs. As part of the Smart Connection Suite, the display is capable of showing process data in graphical formats and communicating messages from the control room, which makes it easier for field operators to determine required maintenance tasks. The transmitter can also be integrated with Honeywell’s Experion Process Knowledge System, through which field operators can identify if the control loop is in a safe state to perform maintenance. A modular design simplifies repairs and reduces cost by allowing replacement of individual components instead of the entire unit. Other safety and efficiency features include enhanced security alerts and wiring polarity insensitivity, through which the transmitter will function correctly even if wiring polarity is reversed.

Carl Zeiss Microscopy
Microscopy is used to monitor cleanliness and evaluate particles

The Axio Zoom.V16 from the Carl Zeiss Microscopy business group allows efficient investigation of a component’s cleanliness in various applications, including pharmaceutical manufacturing. Particles are classed as reflecting or nonreflecting in an automatic process using a motorized, intermediate tube for polarization contrast. The filter analysis with the AxioVision Particle Analyzer software module provides data on the concentration, size distribution, and type of particles. In addition, correlative microscopy, which combines light and electron microscopy, provides chemical information and material classification for individual particles.

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
31%
Breakthrough designations
8%
Protecting the supply chain
42%
Expedited reviews of drug submissions
8%
More stakeholder involvement
12%
View Results
Jim Miller Outsourcing Outlook Jim Miller Health Systems Raise the Bar on Reimbursing New Drugs
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerThe Mainstreaming of Continuous Flow API Synthesis
Jill Wechsler Regulatory Watch Jill Wechsler Industry Seeks Clearer Standards for Track and Trace
Siegfried Schmitt Ask the Expert Siegfried SchmittData Integrity
Sandoz Wins Biosimilar Filing Race
NIH Translational Research Partnership Yields Promising Therapy
Clusters set to benefit from improved funding climate but IP rights are even more critical
Supplier Audit Program Marks Progress
FDA, Drug Companies Struggle with Compassionate Use Requests
Source: Equipment and Processing Report,
Click here